LifeSciences BC is governed by a Board of Directors, whose members represent British Columbia’s biopharmaceutical, biotechnology, medical devices, digital health and greater life sciences community. Our board provides guidance, sets policy and ensures that the organization operates effectively in achieving its mandate, which is to foster the economic development of B.C.’s life sciences industry.
James P. Hatton Q.C. – Partner, Technology Group, Farris, Vaughan, Wills & Murphy LLP
Gordon McCauley – President & CEO, Centre for Drug Research & Development
Ian Heine – Partner, PwC
Ali Ardakani – Founder & Managing Director, Novateur
Andrew Booth – Chief Financial Officer, STEMCELL Technologies Inc.
Robin Ciceri – President, The Research Universities’ Council of BC
Dr. Pieter Cullis – Professor, Department of Biochemistry and Molecular Biology, Faculty of Medicine, UBC
Doug Janzen – Co-Founder and Managing Director, Northview LifeSciences
Gord McCauley – President & CEO, The Centre for Drug Research and Development
Richard Osborn – Managing Partner TELUS Ventures
Scott Phillips – Founder & CEO, Starfish Medical Inc.
Dr. Pascal Spothelfer – President & CEO, Genome BC
Dr. Gavin Stuart – Vice Provost Health, Faculty of Medicine, University of British Columbia
Dr. James Taylor – CEO, Precision Nanosystems Inc.
Observers to the Board
Joseph Garcia – Partner, Blake, Cassels & Graydon LLP
Hector MacKay-Dunn, J.D. Q.C. – Senior Partner, Farris, Vaughan, Wills & Murphy LLP